Discover
SNTI
Senti Biosciences, Inc.
0.37
5 x 0.36
1 x 0.37
bid
ask
+
0.02
5.67%
01:32 PM
timesize
| Ytd | -64.54% | |
| 1y | -75.74% |
0.35
day range
0.37
0.33
52 week range
2.88
| Open | 0.36 | Prev Close | 0.35 | Low | 0.35 | High | 0.37 | Mkt Cap | 11.49M |
| Vol | 92.67K | Avg Vol | 250.33K | EPS | -1.77 | P/E | -0.21 | Forward P/E | -5.33 |
| Beta | 2.10 | Short Ratio | 3.27 | Inst. Own | 23.33% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 0.77 | 200-d Avg | 1.11 | 1yr Est | 12.00 |
| Income Statement | |||
| Total Revenue | 16.00K | ||
| Revenues (USD) | 16.00K | ||
| Gross Profit | 16.00K | ||
| Operating Expenses | 11.51M | ||
| Research and Development Expense | 5.28M | ||
| Selling, General and Administrative Expense | 6.23M | ||
| Operating Income | -11.50M | ||
| Net Income | -4.22M | ||
| Net Income Common Stock | -4.22M | ||
| Net Income Common Stock (USD) | -4.22M | ||
| Consolidated Income | -4.22M | ||
| Earnings per Basic Share | -0.14 | ||
| Earnings per Basic Share (USD) | -0.14 | ||
| Earnings per Diluted Share | -0.14 | ||
| Earning Before Interest & Taxes (EBIT) | -4.22M | ||
| Earning Before Interest & Taxes (USD) | -4.22M | ||
| Weighted Average Shares | 30.97M | ||
| Weighted Average Shares Diluted | 30.97M | ||
| Balance Sheet | |||
| Cash and Equivalents | 12.46M | ||
| Cash and Equivalents (USD) | 12.46M | ||
| Trade and Non-Trade Receivables | 172.00K | ||
| Current Assets | 14.79M | ||
| Property, Plant & Equipment Net | 19.92M | ||
| Total Assets | 38.24M | ||
| Debt Current | 5.89M | ||
| Total Debt | 19.14M | ||
| Current Liabilities | 14.27M | ||
| Debt Non-Current | 13.25M | ||
| Total Liabilities | 35.68M | ||
| Accumulated Retained Earnings (Deficit) | -362.79M | ||
| Shareholders Equity | 2.57M | ||
| Shareholders Equity (USD) | 2.57M | ||
| Assets Non-Current | 23.45M | ||
| Total Debt (USD) | 19.14M | ||
| Deferred Revenue | 2.30M | ||
| Liabilities Non-Current | 21.41M | ||
| Trade and Non-Trade Payables | 1.05M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 688.00K | ||
| Net Cash Flow from Financing | -118.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -7.48M | ||
| Capital Expenditure | 114.00K | ||
| Net Cash Flow from Investing | 114.00K | ||
| Net Cash Flow from Operations | -7.48M | ||
| Share Based Compensation | 1.32M | ||